Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 19 of 19 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro |
 |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham |
| |
Company Arthrolax Solutions | Activity: Research and Development | Company Description Arthrolax Solutions develops devices for the treatment and prevention of joint injuries. | Location Greensboro |
| |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Biocomposites Inc. | Activity: Sales and Operations | Company Description Biocomposites develops, manufactures and distributes calcium compound devices to regenerate and repair bone and soft tissue for use in musculoskeletal infections, trauma, spine and sports injuries. The Wilmington office is a sales office. | Location Wilmington |
| |
Company Bioventus LLC | Activity: Research and Development | Company Description Bioventus develops and markets orthobiologic solutions for musculoskeletal healing and regeneration. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. | Location Durham |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company CytexOrtho | Activity: Research and Development | Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. | Location Durham |
| |
Company Doron Therapeutics | Activity: Research and Development | Company Description Doron Therapeutics is developing an injectable biologic to treat osteoarthritis and other musculoskeletal diseases. | Location Chapel Hill |
| |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham |
| |
Company Kartha Pharmaceuticals Inc. | Activity: Research and Development | Company Description Kartha Pharmaceuticals develops and commercializes pharmaceutical products. | Location Matthews |
| |
Company MitoRainbow Therapeutics Inc. | Activity: Research and Development | Company Description MitoRainbow is developing treatments for TK2 deficiency, a mitochondrial disease that manifests as severe myopathy. | Location Cary |
| |
Company ML Bio Solutions Inc. | Activity: Research and Development | Company Description ML Bio Solutions is developing an oral treatment for patients with limb girdle muscular dystrophy 2i. | Location Charlotte |
| |
Company OsteoCure Therapeutics Inc. | Activity: Research and Development | Company Description OsteoCure Therapeutics develops novel treatments to accelerate and promote bone fracture healing and prevent nonunions. | Location Durham |
| |
Company Plakous Therapeutics Inc. | Activity: Research and Development | Company Description Plakous Therapeutics developed a cell-free placenta extract to prevent necrotizing enterocolitis in premature babies. The cytokines and growth factors purified in the product have anti-inflammatory, regenerative, and immunomodulatory properties analogous to mid-pregnancy amniotic fluid. | Location Winston-Salem |
| |
Company Reselute Inc. | Activity: Research and Development | Company Description Reselute is developing a medical device for the treatment of orthopedic implant related infections. | Location Durham |
| |
Company SP Innovations LLC | Activity: Research and Development | Company Description SP Innovations is developing a graft for irreparable rotator cuff tendon injuries. | Location Raleigh |
| |
Company Sparta Biomedical Inc. | Activity: Research and Development | Company Description Sparta Biomedical is developing cartilage-like implants to mimic the properties of native cartilage and address degeneration in joints. | Location Morrisville |
| |
Company UCB Biosciences Inc. | Activity: Research and Development | Company Description UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis. | Location Morrisville |